BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
Recruiting now · Phase 2
Conditions studied: Triple Negative Breast Cancer
In brief
To study the efficacy, safety, pharmacokinetics and immunogenicity of BCD-236 in combination with chemotherapeutic agents (CHT) in 2nd and subsequent lines of therapy of subjects with relapsed and/or metastatic triple negative breast cancer (TNBC).
Key facts
- Study ID
- NCT07108309
- Run by
- Biocad
- People needed
- 124
- Starts
- 2024-07-15
- Expected to finish
- 2027-05-01
- Last updated by the study team
- 2025-08-07
Who can join
Age: 18 and older, up to 74. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Private medical institution "Euromedservice" — Saint Petersburg, Russia (enrolling)
- "Gomel Regional Clinical Oncology Dispensary" — Homyel, Belarus (enrolling)
- Minsk City Oncology Center — Minsk, Belarus (enrolling)
- Health Institution "Brest Regional Oncology Center" — Brest, Belarus (enrolling)
- SBHI "St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological) named after N.P. Napalkov" — Saint Petersburg, Russia (enrolling)
- SBHI of St. Petersburg "City Clinical Oncology Dispensary" — Saint Petersburg, Russia (enrolling)
- Federal State Budgetary Educational Institution of Higher Education "National Research Mordovian State University named after N.P. Ogarev" — Saransk, Russia (enrolling)
- SBHI Arkhangelsk Region "Severodvinsk City Clinical Hospital No. 2 for Emergency Medicine" — Severodvinsk, Russia (enrolling)
- SAHI Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Bashkortostan — Ufa, Russia (enrolling)
- SBHI of the Yaroslavl region "Regional Clinical Oncological Hospital" — Yaroslavl, Russia (enrolling)
- SBHI "Chelyabinsk regional clinical center Oncology and nuclear medicines" — Chelyabinsk, Russia (enrolling)
- Budgetary healthcare institution of the Udmurt Republic "Republican clinical oncology dispensary named after Sergei Grigorievich Primushko of the Ministry of Health of the Udmurt Republic — Izhevsk, Russia (enrolling)
- SBHI of the Kaluga Region "Kaluga Regional Clinical Oncology Center" — Kaluga, Russia (enrolling)
- State Autonomous Institution of Health "Republican Clinical Oncological Dispensary of the Ministry of Health of the Republic of Tatarstan named after prof. M.Z.Sigal" — Kazan', Russia (enrolling)
- SBHI "Clinical oncological Dispensary № 1" of the Ministry of Health of the Krasnodar Territory — Krasnodar, Russia (enrolling)
- Branch of company "Hadassah Medical LCC" — Moscow, Russia (enrolling)
- Federal State Budgetary Scientific Institution "Russian Scientific Center of Surgery named after Academician B.V. Petrovsky" — Moscow, Russia (enrolling)
- FSAEI of Higher Education "First Moscow State Medical University named after I.M. Sechenov" of the Ministry of Health of the Russian Federation — Moscow, Russia (enrolling)
- FSAEI of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) — Moscow, Russia (enrolling)
- FSAI "National Medical Research Center for Therapeutic and Rehabilitation Center" of the Ministry of Health of the Russian Federation — Moscow, Russia (enrolling)
- FSBI "Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency" — Moscow, Russia (enrolling)
- FSBI "National Medical Research Center of Oncology named after N. N. Blokhin" of the Ministry of Health of the Russian Federation — Moscow, Russia (enrolling)
- Joint Stock Company "Medsi Group of Companies" — Moscow, Russia (enrolling)
- JSC "Modern medical technologies" — Moscow, Russia (enrolling)
- Limited Liability Company "Moscow Center for Rehabilitation Treatment" — Moscow, Russia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.